Talks to replace Novo Nordisk CEO lasted several weeks, board chair says
Published by Global Banking & Finance Review®
Posted on May 16, 2025
1 min readLast updated: January 23, 2026
Published by Global Banking & Finance Review®
Posted on May 16, 2025
1 min readLast updated: January 23, 2026
Novo Nordisk's board has been discussing a CEO change for weeks, surprising outgoing CEO Lars Fruergaard Jorgensen. Helge Lund confirms ongoing talks.
COPENHAGEN (Reuters) -Discussions between Novo Nordisk and the Novo Nordisk Foundation that controls the company regarding a CEO change have been ongoing for the past few weeks, the company's board Chair Helge Lund told Reuters on Friday.
Meanwhile, outgoing Chief Executive Lars Fruergaard Jorgensen told Danish broadcaster TV2 that he was surprised by the decision, and that he had only been informed "very recently".
"I did not see this coming," Fruergaard Jorgensen told TV2.
(Reporting by Maggie Fick in London, writing by Louise Breusch Rasmussen, editing by Terje Solsvik)
The main topic is the ongoing discussions about a CEO change at Novo Nordisk, which have been happening for several weeks.
The outgoing CEO is Lars Fruergaard Jorgensen, who was surprised by the decision.
Novo Nordisk is controlled by the Novo Nordisk Foundation.
Explore more articles in the Finance category


